Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., ...Daha Fazla

LIVER INTERNATIONAL, cilt.35, sa.10, ss.2265-2274, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 10
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1111/liv.12831
  • Dergi Adı: LIVER INTERNATIONAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2265-2274
  • Anahtar Kelimeler: adefovir failure, chronic hepatitis B, genotypic resistance, tenofovir disoproxil fumarate, ADEFOVIR DIPIVOXIL, LAMIVUDINE TREATMENT, TREATMENT FAILURE, NAIVE PATIENTS, THERAPY, MONOTHERAPY, HBV, EMTRICITABINE, POLYMERASE, SAFETY
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background & AimsTo evaluate the efficacy of tenofovir in chronic hepatitis B (CHB) patients with adefovir resistance (ADF-R) and suboptimal response to adefovir (ADF-S).